RIZZI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 484
EU - Europa 86
AS - Asia 75
Totale 645
Nazione #
US - Stati Uniti d'America 484
CN - Cina 45
UA - Ucraina 23
GB - Regno Unito 20
SG - Singapore 17
DE - Germania 15
TR - Turchia 13
SE - Svezia 9
IT - Italia 7
FI - Finlandia 6
BE - Belgio 3
AT - Austria 1
DK - Danimarca 1
FR - Francia 1
Totale 645
Città #
Fairfield 69
Woodbridge 62
Houston 49
Chandler 43
Ashburn 38
Jacksonville 30
Seattle 24
Cambridge 21
Ann Arbor 20
Wilmington 18
San Diego 13
Beijing 12
Nanjing 11
New York 8
Singapore 8
Boardman 7
Izmir 7
Princeton 7
Shanghai 6
Addison 5
Los Angeles 5
Bremen 3
Brussels 3
Santa Clara 3
Shenyang 3
Changsha 2
Falls Church 2
Jiaxing 2
Jinan 2
Nanchang 2
Orange 2
San Mateo 2
Tianjin 2
Washington 2
Acton 1
Auburn Hills 1
Chicago 1
Fuzhou 1
Guangdong 1
Kunming 1
London 1
Miami 1
Philadelphia 1
Rome 1
Simi Valley 1
Verona 1
Vienna 1
Wakefield 1
Totale 507
Nome #
Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity 123
Novel terphenyls and 3,5-diaryl isoxazole derivatives endowed with growth supporting and antiapoptotic properties 118
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 112
Novel combretastatin analogues endowed with antitumor activity 103
The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: Analysis of the possible molecular basis 98
Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells 96
Totale 650
Categoria #
all - tutte 3.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020115 0 0 0 23 11 18 14 13 15 11 8 2
2020/202167 6 5 3 8 2 9 2 11 1 9 7 4
2021/202280 3 6 11 2 3 2 6 2 4 4 7 30
2022/202392 6 6 5 12 16 13 0 11 16 2 5 0
2023/202451 1 5 2 3 6 16 0 3 2 1 0 12
2024/202520 2 4 13 1 0 0 0 0 0 0 0 0
Totale 650